等待開盤 01-12 09:30:00 美东时间
+3.370
+1.43%
今日重点评级关注:Needham:维持Vaxcyte"买入"评级,目标价从90美元升至110美元;Citizens: 维持LGI Homes"跑赢大市"评级,目标价从85美元升至95美元
01-08 18:33
During the last three months, 8 analysts shared their evaluations of Danaher (N...
01-08 05:00
A U.S. appeals court has ruled against the Trump administration’s moves to implement drastic cuts to federal grant funding provided by the National Institutes of Health (NIH) to cover overhead costs i...
01-06 20:16
今日重点评级关注:HC Wainwright & Co.:维持Assertio Holdings"买入"评级,目标价从3美元升至35美元;HC Wainwright & Co.:维持万达生物制药"买入"评级,目标价从20美元升至22美元
01-06 17:52
Guggenheim analyst Subbu Nambi maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $250 to $275.
01-06 00:59
(来源:华夏基石e洞察) 文 /徐继军,华夏基石管理咨询集团副总裁、高级合伙人,华沣管理研究院院长 文章仅代表作者本人观点 【引言:郭...
2025-12-31 08:34
(来源:医趋势) 2025年,全球医疗器械的“寒冬”信号愈发清晰。 自去年起蔓延的裁员潮不仅未止息,反而愈演愈烈——美敦力、强生、飞利浦等超16家顶级医械巨头...
2025-12-29 15:54
In the current session, the stock is trading at $231.47, after a 0.28% spike. O...
2025-12-26 06:00
Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 1.08% ...
2025-12-24 22:00
As 2026 approaches, UBS’ global research team has highlighted 26 stocks that investors should keep on their radar as the new year kicks off. The investment bank identified what it considers its highes...
2025-12-18 02:36